Neurogenetics & Health: A new study explains why Friedreich’s ataxia appears to affect only certain populations, tying the pattern to genetics and consanguinity. Alzheimer’s Drug Discovery: ETH Zurich researchers report an experimental compound that slows nerve-cell death in mice by targeting GRK2, offering a potential early-stage strategy. Parkinson’s Progress: Northwestern University researchers map how dopamine production is disrupted by disease-causing mutations, pointing to earlier, disease-modifying treatment ideas. Biotech & Personalized Medicine: Australian teams grow “mini guts” that include patient intestinal lining plus bacteria to test personalized IBD treatments. Materials for Clean Chemistry: Argonne scientists unveil a hybrid nano-based material that uses sunlight to make hydrogen peroxide more efficiently. Electronics at the Nanoscale: Rice researchers show tiny graphene wrinkles can generate strong electrical effects, suggesting geometry-based control for ultra-thin devices. Public Health & Risk: Researchers warn measles immunity gaps raise travel risk for outbound and inbound travelers. STEM & Society: A Rutgers study links heavy social-media beauty content to higher exposure to hormone-disrupting products among teens. Science Policy & Industry: Cognizant and Benchling will support Kyowa Kirin’s R&D with integrated AI-driven data workflows. Research Ecosystems: Scotland’s Royal Society of Edinburgh restarts its Enterprise Fellowship to help academic researchers turn ideas into scalable companies.